Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Mirabegron (50mg)
Therapeutic Category
Urology, Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹374/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Miratyle 50 Tablet contains Mirabegron (50mg), a beta-3 adrenergic receptor agonist used primarily in the treatment of overactive bladder (OAB). It helps alleviate symptoms such as urinary urgency, frequency, and incontinence by relaxing the bladder’s detrusor muscle, leading to improved bladder capacity and reduced involuntary contractions. Unlike traditional anticholinergics, Miratyle offers a unique and effective option for OAB treatment with a favorable side effect profile, making it suitable for patients who are intolerant or have contraindications to other OAB therapies.
Mirabegron works by targeting the beta-3 receptors in the bladder, promoting smooth muscle relaxation and helping patients regain control over bladder function. It is particularly beneficial for individuals who need long-term management of OAB and may not respond well to anticholinergic medications.
Common side effects may include: Increased blood pressure Headache Nasopharyngitis (common cold symptoms) Dizziness Constipation Serious side effects are rare but may include urinary retention or allergic reactions such as swelling, rash, or breathing difficulties. Consult your doctor if any severe or unusual symptoms develop.
Treatment of overactive bladder (OAB) with symptoms such as urinary urgency, frequency, and incontinence.
Take as prescribed by your healthcare provider. Not recommended for use in patients with uncontrolled high blood pressure. Monitor blood pressure regularly during treatment. Use with caution in patients with renal or hepatic impairment.
Store at room temperature below 25°C, in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.
Composition : Mirabegron (25mg)
Composition : Mirabegron (50mg) + Solifenacin (5mg)
Composition : Ranitidine (75mg/5ml)
Composition : Mirabegron (50mg)
Composition : Letrozole (5mg) Tablet
Composition : Prucalopride (2mg) Tablet
Composition : Prucalopride (1mg) Tablet
Composition : Dienogest (2mg)
Composition : Terbinafine (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.